Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...

Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

China sought to reassure foreign corporate chiefs of the country's business potential when Vice Premier He Lifeng met with ...

Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...

China is making efforts to highlight the country’s business opportunities to major American corporations like Apple (AAPL), ...

The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the ...

Here are three reasons why Pfizer could prove to be a steal of a deal this year. Buying quality stocks at decent valuations ...

Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.

China's Vice Premier He Lifeng sought to reassure foreign corporate chiefs of the country's business potential when he met ...